Sialylated lactosylceramides. Possible inducers of non-specific immunosuppression and atherosclerotic lesions.
Prokazova
N V
NV
Institute of Experimental Cardiology, Cardiology Research Center of the USSR Academy of Medical Sciences, Moscow.
Dyatlovitskaya
E V
EV
Bergelson
L D
LD
D000818:Animals; D015703:Antigens, CD; D001161:Arteriosclerosis / Q000209:etiology*; D006224:Cricetinae; D005679:G(M3) Ganglioside / Q000276:immunology* / Q000378:metabolism; D005732:Gangliosides / Q000276:immunology* / Q000378:metabolism; D006028:Glycosphingolipids / Q000276:immunology* / Q000378:metabolism; D006801:Humans; D007166:Immunosuppressive Agents; D007790:Lactosylceramides; D051379:Mice
D015703:Antigens, CD; D005679:G(M3) Ganglioside; D005732:Gangliosides; D006028:Glycosphingolipids; D007166:Immunosuppressive Agents; D007790:Lactosylceramides; C009744:CDw17 antigen; C026226:ganglioside, GD3